Idera Pharmaceuticals reported $-4178000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbott ABT:US $ 2985M 750M
Agenus AGEN:US $ -34.34M 20.08M
Alnylam Pharmaceuticals ALNY:US $ -181.59M 44.32M
Amgen AMGN:US $ 3004M 337M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Cytrx CYTR:US -1290880 691.86K
Dynavax Technologies DVAX:US $ 128.77M 96.32M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Gilead Sciences GILD:US $ 2585M 837M
GlaxoSmithKline GSK:LN 2447M 673M
Idera Pharmaceuticals IDRA:US $ -4.18M 0.06M
Mirati Therapeutics MRTX:US $ -176.51M 7.08M
Nektar Therapeutics NKTR:US $ -44.27M 67.08M
Pfizer PFE:US $ 12921M 1739M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Seattle Genetics SGEN:US $ -115.89M 0.06M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M